These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 14990394)

  • 41. Lower blood pressure and risk of recurrent stroke in patients with chronic kidney disease: PROGRESS trial.
    Ninomiya T; Perkovic V; Gallagher M; Jardine M; Cass A; Arima H; Anderson C; Neal B; Woodward M; Omae T; MacMahon S; Chalmers J;
    Kidney Int; 2008 Apr; 73(8):963-70. PubMed ID: 18272959
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Angiotensin-converting enzyme inhibitor use is associated with reduced plasma concentration of C-reactive protein in patients with first-ever ischemic stroke.
    Di Napoli M; Papa F
    Stroke; 2003 Dec; 34(12):2922-9. PubMed ID: 14605324
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Progress in reducing the burden of stroke.
    Chalmers J; Chapman N
    Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):1091-5. PubMed ID: 11903323
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of perindopril on left ventricular structural and functional parameters in patients with preserved systolic function after myocardial infarction. Relation to polymorphism of angiotensin converting enzyme gene].
    Tereshchenko SN; Dzhaiani NA; Moiseev VS; Nosikov VV
    Kardiologiia; 2002; 42(5):38-41. PubMed ID: 12494147
    [No Abstract]   [Full Text] [Related]  

  • 45. Examination of selected clinical factors and medication use as risk factors for pneumonia during stroke rehabilitation: a case-control study.
    Marciniak C; Korutz AW; Lin E; Roth E; Welty L; Lovell L
    Am J Phys Med Rehabil; 2009 Jan; 88(1):30-8. PubMed ID: 19096289
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angiotensin-converting enzyme inhibitor use and protection against pneumonia in patients with diabetes.
    van de Garde EM; Souverein PC; Hak E; Deneer VH; van den Bosch JM; Leufkens HG
    J Hypertens; 2007 Jan; 25(1):235-9. PubMed ID: 17143196
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Blood pressure lowering for the prevention of cognitive decline in patients with cerebrovascular disease. PROGRESS Management Committee. Perindopril Protection Against Recurrent Stroke Study.
    Whitlock G; MacMahon S; Anderson C; Neal B; Rodgers A; Chalmers J
    Clin Exp Hypertens; 1997; 19(5-6):843-55. PubMed ID: 9247759
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease.
    Bath P; Algert C; Chapman N; Neal B;
    Stroke; 2004 Mar; 35(3):622-6. PubMed ID: 14976328
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Post-stroke pneumonia prevention by angiotensin-converting enzyme inhibitors: results of a meta-analysis of five studies in Asians.
    Shinohara Y; Origasa H
    Adv Ther; 2012 Oct; 29(10):900-12. PubMed ID: 22983755
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ACE inhibitors and pneumonia.
    Sekizawa K; Matsui T; Nakagawa T; Nakayama K; Sasaki H
    Lancet; 1998 Sep; 352(9133):1069. PubMed ID: 9759784
    [No Abstract]   [Full Text] [Related]  

  • 51. Impact of blood pressure lowering on cardiovascular outcomes in normal weight, overweight, and obese individuals: the Perindopril Protection Against Recurrent Stroke Study trial.
    Czernichow S; Ninomiya T; Huxley R; Kengne AP; Batty GD; Grobbee DE; Woodward M; Neal B; Chalmers J
    Hypertension; 2010 May; 55(5):1193-8. PubMed ID: 20212271
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of a perindopril-based blood-pressure-lowering regimen in patients with previous stroke or transient ischaemic attack (progress). How do the results affect practice in Pakistan?
    Khan M; Kamal AK
    J Pak Med Assoc; 2010 Jul; 60(7):597-8. PubMed ID: 20578620
    [No Abstract]   [Full Text] [Related]  

  • 53. Effects of the end point adjudication process on the results of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS).
    Ninomiya T; Donnan G; Anderson N; Bladin C; Chambers B; Gordon G; Sharpe N; Chalmers J; Woodward M; Neal B;
    Stroke; 2009 Jun; 40(6):2111-5. PubMed ID: 19359647
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of the angiotensin converting enzyme inhibitor, perindopril, on heart rhythm variability and adrenoreactivity in patients with ischemic heart disease associated with duodenal ulcer].
    Linnik SA; Naurbieva EN; Ponomareva EP
    Kardiologiia; 2007; 47(4):41-4. PubMed ID: 18260837
    [No Abstract]   [Full Text] [Related]  

  • 55. The Effects of a Perindopril-Based Regimen in Relation to Statin Use on the Outcomes of Patients with Vascular Disease: a Combined Analysis of the ADVANCE, EUROPA, and PROGRESS Trials.
    Radhoe SP; Boersma E; Bertrand M; Remme W; Ferrari R; Fox K; MacMahon S; Chalmers J; Simoons ML; Brugts JJ
    Cardiovasc Drugs Ther; 2024 Feb; 38(1):131-139. PubMed ID: 36194352
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reducing dementia and cognitive decline in stroke patients.
    Cardiovasc J S Afr; 2002; 13(4):215-6. PubMed ID: 12402930
    [No Abstract]   [Full Text] [Related]  

  • 57. Multimodal effects of available drugs for ischemic stroke.
    Chen M; Selim M
    Timely Top Med Cardiovasc Dis; 2005 Sep; 9():E29. PubMed ID: 16341281
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Angiotensin-converting enzyme inhibitors, angiotensin-II receptor antagonists, and pneumonia in elderly hypertensive patients with stroke.
    Arai T; Yasuda Y; Takaya T; Toshima S; Kashiki Y; Shibayama M; Yoshimi N; Fujiwara H
    Chest; 2001 Feb; 119(2):660-1. PubMed ID: 11171758
    [No Abstract]   [Full Text] [Related]  

  • 59. Use of ACE inhibitors and risk of community-acquired pneumonia: a review.
    Rafailidis PI; Matthaiou DK; Varbobitis I; Falagas ME
    Eur J Clin Pharmacol; 2008 Jun; 64(6):565-73. PubMed ID: 18320184
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ACE inhibitors and reduction of the risk of pneumonia in elderly people.
    Arai T; Yasuda Y; Takaya T; Toshima S; Kashiki Y; Yoshimi N; Shibayama M; Fujiwara H
    Am J Hypertens; 2000 Sep; 13(9):1050-1. PubMed ID: 10981561
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.